Cellectis (CLLS) Share-based Compensation: 2015-2023
Historic Share-based Compensation for Cellectis (CLLS) over the last 9 years, with Dec 2023 value amounting to $4.6 million.
- Cellectis' Share-based Compensation rose 1094.06% to $4.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.2 million, marking a year-over-year decrease of 13.40%. This contributed to the annual value of $3.2 million for FY2024, which is 39.48% down from last year.
- Latest data reveals that Cellectis reported Share-based Compensation of $4.6 million as of Q4 2023, which was up 274.18% from -$2.7 million recorded in Q3 2023.
- Cellectis' Share-based Compensation's 5-year high stood at $8.0 million during Q3 2019, with a 5-year trough of -$2.8 million in Q4 2020.
- In the last 3 years, Cellectis' Share-based Compensation had a median value of $1.8 million in 2021 and averaged $1.9 million.
- In the last 5 years, Cellectis' Share-based Compensation surged by 7,620.00% in 2022 and then crashed by 299.62% in 2023.
- Cellectis' Share-based Compensation (Quarterly) stood at $7.1 million in 2019, then slumped by 139.19% to -$2.8 million in 2020, then soared by 169.53% to $1.9 million in 2021, then tumbled by 79.98% to $387,000 in 2022, then surged by 1,094.06% to $4.6 million in 2023.
- Its Share-based Compensation was $4.6 million in Q4 2023, compared to -$2.7 million in Q3 2023 and $1.6 million in Q2 2023.